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A 61-year-old man who had undergone remote orthotopic
liver transplant was admitted for fever and progressive
dyspnea of several days duration. A chest radiograph
demonstrated bilateral interstitial infiltrates with diffuse
patchy alveolar opacities. The patient was treated empirically
for presumed pulmonary infection with broad-spectrum
antibiotics. High-dose trimethoprim/sulfamethoxazole was
initiated 24 h after admission because of continued fevers and
concern for Pneumocystis carinii pneumonia. Bronchoscopy
was performed and direct fluorescent antibody staining for
Pneumocystis carinii pneumonia was positive, confirming the
diagnosis.
Before admission, the patient carried a diagnosis of
chronic kidney disease because of toxicity from calcineurin
inhibitors, which had since been discontinued. Seventy-two
hours after presentation and despite ongoing intravenous
hydration, the patient’s creatinine increased from a baseline
of 1.6 mg per 100 ml (122 mmol/l) to 3.4 mg per 100 ml
(259 mmol/l), representing a decline in estimated glomerular
filtration rate of 42–19 ml/min per 1.73 m2. Urine output had
also decreased dramatically. Renal ultrasound was unremark-
able with no evidence for obstruction. By initial dipstick
analysis, the urine had pH of 5.0, specific gravity 1.020,
negative blood, trace protein, and negative leukocyte esterase.
A microscopic evaluation of the urine sediment demon-
strated rare granular casts, no red blood cells, rare white
blood cells per high-powered field, and innumerable yellow-
brown crystals as depicted (Figure 1).
What is the cause of the patient’s renal failure based on the findings of the urine
sediment?
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Figure 1 | Microscopic urine analysis. (a) Numerous yellow-brown
oval and fan-shaped crystals are noted throughout the microscopic
field, original magnification  10. (b) Original magnification  40.
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The Diagnosis | Sulfonamide crystalluria
Although the patient appeared dehydrated, his creatinine
worsened despite intravenous saline. No other nephrotoxic
agents had been administered, and no evidence suggested
acute interstitial nephritis from antimicrobials. We supposed
that intratubular obstruction from the observed sulfonamide
crystalluria was a significant contributor to the acute
kidney injury. The trimethoprim/sulfamethoxazole was
replaced with an alternative antimicrobial, and intravenous
isotonic sodium bicarbonate was administered for
hydration and alkalinization. Within 96 h, the crystalluria
resolved (Figure 2), leaving only monomorphic hematuria
from the bladder catheter trauma. The patient’s creatinine
returned near his baseline to 1.8 mg per 100 ml (137 mmol/l),
and he recovered from his respiratory illness to be
discharged.
Acute renal failure from sulfonamide crystalluria is
reported to occur in 0.4–29% of patients, and typically
develops approximately 7 days after drug initiation, although
it may be seen sooner. As they are weak acids, sulfonamides
crystallize in sufficiently acidic urine (pHp5.5), causing
intratubular obstruction and acute decline in renal function.1
High doses, such as those used to treat Pneumocystis carinii
pneumonia and toxoplasmosis, increase the probability of
crystal formation. Hypoalbuminemia and dehydration,
which were both present in our patient, also contribute to
urinary precipitation of these drugs and their metabolites.1,2
Renal ultrasound may demonstrate echogenic foci in the
renal parenchyma or collecting system.3 Crystals are typically
amber in color, and their shapes may be needle-shaped,
rosettes, dumbbells, or ‘shocks of wheat,’ and may be specific
to the sulfonamide-derivative administered.2,4 A Lignin test,
in which 10% hydrochloric acid is mixed with urine,
produces a yellowish-orange color when sulfa is present,1
allowing detection of these drugs.
Treatment of acute kidney injury from sulfonamide
crystalluria is comprised of withdrawal of the drug, hydration
and/or diuretics to establish high urine flow, and alkaliniza-
tion to maintain urine pH 47.15.1,2 Rarely, ureteral
catheterization, nephrostomy tube placement, or even
hemodialysis is necessary. Reintroduction or even continua-
tion of the drug may be tolerated with aggressive hydration
and urinary alkalinization.1
Patients receiving high doses of sulfonamide to treat
opportunistic infections are prone to acute kidney injury
from crystalluria. A microscopic analysis of the urine
sediment is an inexpensive but essential tool in suggesting
this diagnosis. Familiarity with the characteristic appearance
of sulfa crystals allows rapid supportive and therapeutic
intervention.
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Figure 2 | Resolution of crystalluria following
withdrawal of sulfonamide. Only monomorphic
hematuria remains, original magnification 40.
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